Sydney, Australia, 25 August 2021 – The International Myopia Institute (IMI) has developed the IMI Facts and Findings Infographic for practitioners based on the IMI White Papers published in 2019 and 2021. The IMI Facts and Findings Infographic will create more awareness about myopia as a public health issue while providing a useful chairside reference of key myopia management evidence-based information easily accessed by practitioners.
The IMI White Papers were authored by over one hundred experts in the field of myopia, and comprehensively cover a range of areas including: definitions and classifications, genetics, experimental models, interventions, risk factors, impact of myopia, accommodation and binocular vision, myopia control trials and instrumentation, industry guidelines and ethical considerations, pathologic myopia, clinical management guidelines, and a yearly digest update. The white papers and clinical summaries are available in many international languages.
“This carefully crafted infographic summarises some of the key evidence-based findings of the International Myopia Institute’s white papers; it can be used by eye care practitioners to communicate these to involve patients in their management,” – Chief Scientist Professor James Wolffsohn.
“We are excited to share a much needed resource that will be used widely by practitioners around the world in supporting evidence-based myopia management. The IMI Facts and Findings Infographic will help to support practitioner-patient communication which is a critical part of successful myopia management,” – Dr Monica Jong, IMI Executive Director.
The IMI Facts and Findings Infographic can be downloaded for free at myopiainstitute.org.
ABOUT THE INTERNATIONAL MYOPIA INSTITUTE
The International Myopia Institute was formed following the WHO-BHVI meeting on myopia and high myopia in 2015, due to the need to address the increasing levels of myopia and high myopia worldwide that can lead to potentially sight threatening complications for an individual, and the massive global burden associated with lost productivity.
The IMI is a global group of experts who have come together to discuss, debate and make available the latest evidence-based recommendations in classifications, patient management, and research, in the form of the IMI white papers.
Our mission is to advance research, patient management and education in myopia to prevent future vision impairment and blindness associated with increasing myopia. We aim to do this by bringing together, scientists, clinicians, policy makers, government and educators into the field of myopia to stimulate collaboration and sharing of knowledge.
Founded by Brien Holden Vision Institute (BHVI).
Supported by Zeiss, Essilor, CooperVision, Alcon and OCULUS.
For further information, please contact the IMI.